4th Quarter - Report

SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE

Firm
Client
Income
—
Expenses
$20,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY20 and FY21 Labor-Health and Human Services-Education appropriations/maternal and infant health/AHRQ/NIH/CDC/HRSA

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ)

Health Issues HCR

S. 916/HR 1897 MOMMA's Act (maternal mortality); S. 116 MOMS Act (maternal health); HR 2902/ S 1600 Maternal CARE Act; HR 1551/S 1960 Quality Care for Moms and Babies Act; maternal mortality, severe maternal morbidity, research in pregnancy; Healthy Start

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1551 (116th), H.R. 1897 (116th), S. 116 (116th), S. 916 (116th), H.R. 2902 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.